The Department of Drug Administration clarified on Thursday that immunosuppressant medicines have not been banned from sale, distribution or use in Nepal, following confusion over a recent notice. The department said the restrictions concern only the new production and import of 47 brands that either failed to meet prescribed standards or did not submit required risk assessment documents within the given time. It said the supply of the medicines would continue smoothly.
Nepal Drug Department Says No Ban on Immunosuppressant Medicines
The Department of Drug Administration says sales, distribution and use of immunosuppressant medicines will continue, while restrictions apply only to new production and imports of 47 brands.
The Patrukar
29 Aswin 2083
BS
1 min read
Sources
Clustered via K cha khabar.
